Wade Steeves, MD has joined Rocky Mountain MS Clinic

The FDA approval of ISEMBYLD™ brings a new treatment option to the SMA community. At CTNC, Dr. Adam Horvit and our team care for six patients receiving apitegromab through an Expanded Access Program.

At ECTRIMS 2025, Dr. John Foley joined experts from around the world to explore how AI-powered analysis of real-world clinical data can provide new insights into drug efficacy, safety, and outcomes in multiple sclerosis. He was joined at the meeting by many neurologists and APPs from across the Nira Medical network, who participated in research presentations, discussions, and the broader exchange of ideas in MS care.

Nira Medical was proud to be part of AAN 2026 through research presentations and panel discussions spanning community-based research, patient experience, and expanding brain health beyond the clinic.